Literature DB >> 1673192

Should we tell trial patients that they might receive placebo?

E Skovlund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1673192     DOI： 10.1016/0140-6736(91)92701-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Preferences and understanding their effects on health.

Authors:  K McPherson; A Britton
Journal:  Qual Health Care       Date:  2001-09

Review 2.  Placebo effects: clinical aspects and neurobiology.

Authors:  Barry S Oken
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

3.  Reframing placebo in research and practice.

Authors:  Wayne B Jonas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

Review 4.  Placebo controls: historical, methodological and general aspects.

Authors:  Harald Walach
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

5.  Influence of the behaviour pattern on the nocebo response of healthy volunteers.

Authors:  M D Drici; F Raybaud; C De Lunardo; P Iacono; P Gustovic
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

Review 6.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 7.  [Clinical significance of the placebo effect].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

8.  Circular instead of hierarchical: methodological principles for the evaluation of complex interventions.

Authors:  Harald Walach; Torkel Falkenberg; Vinjar Fønnebø; George Lewith; Wayne B Jonas
Journal:  BMC Med Res Methodol       Date:  2006-06-24       Impact factor: 4.615
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.